David Cappellen
Impact in
- Dermatology top 2%
- Cutaneous lymphoproliferative disorders research
- Molecular Biology top 5%
- Fibroblast Growth Factor Research
- Epigenetics and DNA Methylation
- Bone Metabolism and Diseases
- Kruppel-like factors research
Papers in
-
- Epigenetics and DNA Methylation 7
- CRISPR and Genetic Engineering 6
- Fibroblast Growth Factor Research 5
- Oncology 12
- Cancer-related Molecular Pathways 4
- Co-authors
- Jean Paul Thiery (6 shared papers)François Radvanyi (6 shared papers)Dominique Chopin (7 shared papers)Mira Šuša (3 shared papers)Natasa Zamurovic (2 shared papers)Xavier Sastre‐Garau (2 shared papers)J.-S. Bourdin (2 shared papers)Catherine De Oliveira (1 shared paper)
- Journals
- Nature Communications (3 papers)PLoS ONE (3 papers)Oncogene (2 papers)Oncotarget (2 papers)International Journal of Cancer (2 papers)
- Partner nations
- FranceSwitzerlandBrazil
In The Last Decade
David Cappellen
49 papers receiving 2.3k citations
David Cappellen's Hit Papers
Peers
Comparison fields: 5 of 96
- Dermatology 194
- Molecular Biology 1.5k
- Oncology 497
- Cancer Research 249
- Pathology and Forensic Medicine 278
Countries citing papers authored by David Cappellen
This map shows the geographic impact of David Cappellen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cappellen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cappellen more than expected).
Fields of papers citing papers by David Cappellen
This network shows the impact of papers produced by David Cappellen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cappellen. The network helps show where David Cappellen may publish in the future.
Co-authors
The 25 scholars most cited alongside David Cappellen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas Hit paper breakdown → | 1999 | 567 |
| 2 | 2004 | 212 | |
| 3 | 2002 | 162 | |
| 4 | 2005 | 114 | |
| 5 | 1999 | 110 | |
| 6 | 2009 | 106 | |
| 7 | 2004 | 96 | |
| 8 | 1997 | 95 | |
| 9 | 2006 | 85 | |
| 10 | 2013 | 85 | |
| 11 | 2014 | 84 | |
| 12 | 2005 | 60 | |
| 13 | 2013 | 60 | |
| 14 | 2021 | 54 | |
| 15 | 2013 | 50 | |
| 16 | 2015 | 45 | |
| 17 | 2013 | 41 | |
| 18 | 2016 | 35 | |
| 19 | 2008 | 32 | |
| 20 | 2022 | 31 |
About David Cappellen
David Cappellen is a scholar working on Molecular Biology, Oncology, Cancer Research, Dermatology and Surgery, having authored 51 papers that have together received 2.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (7 papers), Cutaneous lymphoproliferative disorders research (7 papers), CRISPR and Genetic Engineering (6 papers), Fibroblast Growth Factor Research (5 papers), Cancer Genomics and Diagnostics (4 papers), Cancer-related Molecular Pathways (4 papers), Neuroblastoma Research and Treatments (3 papers) and T-cell and Retrovirus Studies (3 papers). The work is most often cited by research in Dermatology (194 citations), Molecular Biology (1.5k citations), Oncology (497 citations), Cancer Research (249 citations) and Pathology and Forensic Medicine (278 citations). David Cappellen has collaborated with scholars based in France, Switzerland and Brazil. Frequent co-authors include Jean Paul Thiery, François Radvanyi, Dominique Chopin, Mira Šuša, Natasa Zamurovic, Xavier Sastre‐Garau, J.-S. Bourdin, Catherine De Oliveira, Jean‐Philippe Merlio and B. Vergier. Their work appears in journals such as Nature Communications, PLoS ONE, Oncogene, Oncotarget and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.